Baldry Mark — SEC Form 4 filings
SEC reporting owner CIK 1644137. 6 Form 4 filings on record with FilingPulse; latest filed 2025-06-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-16 to 2025-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 36,082 shares, $21,813 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 40,286 shares, $19,747 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 5.
- Largest priced transaction: purchase of 21,646 shares @ $0.68 ($14,654) in X4 Pharmaceuticals, Inc, filed 2025-02-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | 6 | 3 legs · 36,082 sh · $21,813 | 2 legs · 40,286 sh · $19,747 | 5 |
Form 4 filings — Baldry Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-03 | 4/A | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 1,032 @ $2.48 | EDGAR |
| 2025-05-20 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Purchase (P): 1,032 @ $2.48 | EDGAR |
| 2025-02-14 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Purchase (P): 21,646 @ $0.68 · Purchase (P): 13,404 @ $0.34 · Grant/award (A): 600,000 @ $0 | EDGAR |
| 2025-01-27 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 74,773 @ $0 · Sale (S): 29,159 @ $0.45 | EDGAR |
| 2024-10-08 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 34,946 @ $0 · Sale (S): 11,127 @ $0.58 | EDGAR |
| 2024-02-16 | 4 | X4 Pharmaceuticals, Inc (XFOR) | Grant/award (A): 523,414 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1644137 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →